Key result
Angiotensin II protected human erythrocytes from hypo-osmotic conditions-induced hemolysis by activating AT2 receptors and triggering intracellular pathways.
Why the study?
Given that cell integrity is an important feature of mature erythrocytes, this study evaluated in vitro whether angiotensin II modulates resistance to hemolysis and the signaling pathway involved.
In vitro, Angiotensin II protects human erythrocytes from hypo-osmotic hemolysis through AT2 receptor activation and intracellular p38 and PI3K/Akt signaling pathways.
Answers are grounded in this paper and cite their sources.
In vitro Ang II protection of erythrocytes via AT2 leaves open any in vivo or clinical relevance; hypothesis-generating only.
BACKGROUND: Angiotensin II regulates blood volume via AT1 (AT1R) and AT2 (AT2R) receptors. As cell integrity is an important feature of mature erythrocyte, we sought to evaluate, in vitro, whether angiotensin II modulates resistance to hemolysis and the signaling pathway involved. METHODS: Human blood samples were collected and hemolysis assay and angiotensin II signaling pathway profiling in erythrocytes were done. RESULTS: M). Angiotensin II demonstrated protective effect, both in osmotic stressed and physiological situations, by reducing hemolysis in NaCl 0.4% and 0.9%. By adding receptors antagonists (losartan, AT1R antagonist and PD 123319, AT2R antagonist) and/or signaling modulators for AMPK, Akt/PI3K, p38 and PKC we showed the protective effect was enhanced with losartan and abolished with PD 123319. Also, we showed activation of p38 as well as PI3K/Akt pathways in this system. CONCLUSION: Ang II protects human erythrocytes from hypo-osmotic conditions-induced hemolysis by activating AT2 receptors and triggering intracellular pathways.
No takes yet. Share an insight, caveat, or question.
Guimarães-Nobre et al. (2021) studied this question. Angiotensin II was evaluated on Hemolysis in NaCl 0.4% and 0.9%. Angiotensin II protected human erythrocytes from hypo-osmotic conditions-induced hemolysis by activating AT2 receptors and triggering intracellular pathways.
Synapse has enriched 10 related papers. Consider them for comparative context: